StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Morgan Stanley Downgrades Teva Pharma (TEVA) to Underweight
August 7, 2017 6:23 AM
(Updated - August 7, 2017 7:14 AM EDT)
(updated to add analyst comment)Morgan Stanley downgraded Teva Pharma (NYSE: TEVA) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Downgrades
Hot Comments
Hot Downgrades
Next Articles
Teva Pharma (TEVA) Grinds Lower, Shares Down Another 9%
August 7, 2017 2:58 PM
Teva Pharma (TEVA) Granted FDA Approval of QVAR® RediHaler (Beclomethasone Dipropionate HFA) Inhalation Aerosol
August 7, 2017 8:01 AM